beta(1)-adrenoceptor polymorphisms: deviation of clinical outcome with use of beta-blockers in ventricular dysfunction.
While the debate continues regarding the role of polymorphisms of beta(1)-adrenoceptors on the clinical outcomes and beneficial effects of beta-blockers in patients with heart failure, we need to step back and examine the evidence in the peer-reviewed literature more closely.